GeminIQ Website Logo

Viewing CDIX free

Subscribe for full history, 50+ metrics, screener, watchlist...

Cardiff Lexington Corp

CDIX

Companies in Services-Offices & Clinics of Doctors of Medicine

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash
100111231100
Accounts Receivable Net Current
23222119181615151513129
Prepaid Expense And Other Assets Current
000000000000
Assets Current
242321201917171816141210
Property Plant And Equipment Net
000000000000
Inventory Real Estate
111111111111
Goodwill
666666666666
Operating Lease Right Of Use Asset
000000000000
Other Assets
000000000000
Assets
302928272524242523211916
Liabilities Current
Accounts Payable And Accrued Liabilities Current
222121122233
Interest Payable Current
111110001111
Operating Lease Liability Current
000000000000
Notes Payable Current
000000114000
Lines Of Credit Current
1917151310977-2--
Convertible Debt Current
000000004444
Liabilities Of Disposal Group Including Discontinu…
1000000000--
Liabilities Current
242622201816151415141211
Operating Lease Liability Noncurrent
000000000000
Other Long Term Notes Payable
000000000000
Liabilities
252623211816151415141212
Temporary Equity Carrying Amount Attributable To P…
---55-5-----
Redeemable Noncontrolling Interest Equity Preferre…
--5---------
Temporary Equity Value Excluding Additional Paid I…
26---5-56655
Common Stock Value
000000000011
Additional Paid In Capital
777230302323212014-9-9-8
Deferred Compensation Equity
-0-1---0------
Retained Earnings Accumulated Deficit
-83-79-77-75-74-73-72-70-69-69-69-71
Stockholders Equity
4-2-012346111-1
Liabilities And Stockholders Equity
302928272524242523211916
Debt Instrument Unamortized Discount
-0---000000-
Debt Instrument Unamortized Discount Current
1----------0
Common Stock Shares Authorized
1,8001,8001,8001,8001,8001,8001,8001,8001,8001,8751,8751,875
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Issued
9196100989292878281756959
Shares Outstanding
9196100989292878281756959

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-21.95%-33.04%----------
20250.00%0.00%-56.13%0.00%8.00%0.00%15.38%43.08%28.21%-22.03%-35.48%-35.48%
202475.00%75.00%75.00%0.00%0.00%0.00%-7.14%-55.71%-55.71%0.00%0.00%0.00%
20230.00%-50.00%-50.00%700.00%100.00%-33.33%-50.00%-50.00%-90.00%0.00%-46.15%7.69%
2022---------100.00%-16.67%-66.67%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.98
0.87
0.94
0.98
1.04
1.08
1.14
1.30
1.06
1.02
1.01
0.84
Quick Ratio
0.97
0.87
0.94
0.97
1.03
1.08
1.14
1.30
1.06
1.02
1.01
0.84
Working Capital
-501.74K
-3.24M
-1.34M
-423.29K
717.47K
1.33M
2.11M
4.18M
915.38K
316.63K
136.95K
-1.89M
Leverage & Debt
Debt to Equity
6.35
-10.53
-62.00
27.26
8.95
6.08
4.03
2.41
12.69
19.31
17.91
-10.86
Interest Coverage TTM
0.01
0.16
0.36
0.17
0.04
-0.06
-0.06
4.27
3.22
4.86
5.00
5.41
Debt Ratio
0.81
0.89
0.82
0.77
0.72
0.68
0.64
0.57
0.68
0.68
0.65
0.73
Efficiency & Turnover
Asset Turnover TTM
0.39
0.44
0.46
0.40
0.37
0.37
0.36
0.47
0.62
0.70
0.63
0.76
Days Sales Outstanding TTM
679.90
601.27
545.14
610.45
662.01
645.24
646.08
458.43
351.61
306.53
313.86
261.37
Receivables Turnover TTM
0.54
0.61
0.67
0.60
0.55
0.57
0.56
0.80
1.04
1.19
1.16
1.40
Per Share Metrics
Diluted EPS TTM
-0.65
-0.38
-0.25
-0.29
-0.22
-0.21
-0.17
0.04
0.10
0.12
-6.51
-17.61
Free Cash Flow Per Share TTM
-0.29
-0.34
-0.16
-0.19
-0.16
-0.27
-0.35
-0.31
-0.35
-0.25
-0.18
-0.14
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
61.65%
62.47%
62.83%
58.07%
55.23%
53.55%
50.66%
65.92%
69.03%
69.96%
69.59%
63.95%
Operating Profit Margin TTM
0.42%
9.54%
17.92%
8.85%
1.48%
-2.34%
-1.47%
28.69%
40.60%
43.83%
49.23%
42.41%
Net Profit Margin TTM
-87.21%
-56.71%
-41.11%
-53.59%
-50.01%
-51.57%
-41.21%
7.39%
17.27%
18.97%
-11.92%
-31.45%
Growth Metrics
Net Revenue Growth (1Y)
22.32%
39.48%
57.91%
6.32%
-22.72%
-30.23%
-30.69%
-11.13%
9.20%
10.85%
-14.94%
-15.50%
Net Income Growth (1Y)
113.31%
53.38%
57.54%
-871.23%
-323.74%
-289.70%
139.66%
-120.87%
-146.43%
-138.67%
-181.48%
-187.15%
EPS Growth (1Y)
99.97%
12.61%
12.24%
-626.17%
-225.48%
-234.67%
71.73%
-115.18%
-135.35%
-131.18%
-170.29%
-197.28%
Valuation Metrics
P/E TTM
-3.97
-11.91
-12.13
-21.31
-28.57
-22.18
-63.54
253.19
75.16
144.55
-116.92
-247.01
P/B TTM
9.68
-31.56
-162.63
154.27
62.19
35.24
52.84
30.46
123.08
444.33
223.91
-779.23
P/S TTM
3.46
6.76
4.99
11.42
14.29
11.44
26.18
18.70
12.98
27.42
13.93
77.69
Market Cap
37.53M
77.94M
59.27M
116.26M
126.63M
94.61M
197.05M
179.10M
148.91M
324.99M
151.29M
837.21M
Enterprise Value
56.10M
95.08M
74.01M
128.77M
136.26M
102.49M
203.18M
183.24M
155.08M
331.00M
155.09M
840.70M
Calculated Values
Free Cash Flow TTM
-4.27M
-4.74M
-2.05M
-2.38M
-2.22M
-2.77M
-3.29M
-2.68M
-2.68M
-1.81M
-1.24M
-886.75K
Net Debt
18.57M
17.14M
14.75M
12.51M
9.63M
7.87M
6.13M
4.14M
6.17M
6.01M
3.80M
3.48M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2018-10-30Sale
Owner: Mccarthy, David Lawrence
Title: -
Shares: 30,000,000
Price/Share: $0.00
Value: -
Shares Owned: -
Relationship: TenPercentOwner
Ownership: Direct

Subscribe to unlock 17+ years of data

No institutional ownership data available.

Cardiff Lexington Corp (CDIX) — SEC Financial Statements & Analysis

Cardiff Lexington Corp (CDIX) is a services-offices & clinics of doctors of medicine company, incorporated in FL. Cardiff Lexington Corp trades on CDIX: OTC as: CDIX. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Cardiff Lexington Corp reported a 22.32% year-over-year revenue growth, a Gross Profit Margin of 61.65% (TTM), a Debt-to-Equity ratio of 6.35x, a Price-to-Sales (P/S) ratio of 3.46x (TTM), a Price-to-Book (P/B) ratio of 9.68 (TTM), at a market cap of $37.53M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
22.32%
Gross Profit Margin TTM
61.65%
Debt To Equity
6.35x
P/S TTM
3.46x
P/B TTM
9.68
Market Cap
$37.53M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Cardiff Lexington Corp in?

Cardiff Lexington Corp (CDIX) operates in the Services-Offices & Clinics of Doctors of Medicine industry.

What is CDIX's market cap?

Cardiff Lexington Corp (CDIX) has a market capitalization of $37.53M as of 2026-03-31.

What exchange does CDIX trade on?

Cardiff Lexington Corp (CDIX) trades on the CDIX: OTC.

Where is Cardiff Lexington Corp incorporated?

Cardiff Lexington Corp is incorporated in FL.

Research Faster.
Invest Smarter.

Cardiff Lexington Corp (CDIX) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.